Trifarotene

DB12808ApprovedInvestigationalSmall moleculeRetinoids

Trifarotene is a topical retinoid indicated for the treatment of acne vulgaris. Retinoids are a class of medications structurally and functionally analogous to vitamin A, though later generation retinoids such as trifarotene and adapalene bear little structural resemblance to vitamin A and are analogous only in function.

Chemical structure of Trifarotene
Mechanism
Curator reviewed · 3 references
Primary indication
Trifarotene is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older.Curator reviewed · 1 structured indication
Formula / weight
C29H33NO4 · 459.586 g/mol (avg)
First approval
Canada, 2019 · United States, 2019
Code names
CD-5789
Brand names
  • Aklief

Resolves to

Structure
InChIKeyMFBCDACCJCDGBA-UHFFFAOYSA-NSMILESCC(C)(C)C1=CC(=CC=C1N1CCCC1)C1=CC(=CC=C1OCCO)C1=CC=C(C=C1)C(O)=O

What you can answer from here — as of September 25, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
7Marketed productsAcross 4 countries and 2 labellers
Sign in
1ATC codeIncluding every combination product, plus 14 drug categories
Sign in
22+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Trifarotene, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account